Organoids Promise to Accelerate Parkinson's and Alzheimer’s Research and Drug Discovery
In Biocompare, Oksana Sirenko, Ph.D., Senior Manager of Assay Development at Molecular Devices, explores how human iPSC-derived 3D brain organoids are advancing neuroscience and drug discovery. Drawing on her expertise in assay development, she explains how these models better replicate human brain complexity and functionality, enabling more predictive disease research and therapeutic testing for conditions like Alzheimer’s and Parkinson’s.